Home » Newsletters » BioWorld Science

BioWorld Science

April 5, 2011

View Archived Issues

Noninvasive method predicts organ rejection using donor DNA levels in transplant recipient's plasma

Lab-on-a-chip device SIMBAS enables quick separation of parasites from human blood

Antitumor effects of tolfenamic acid correlate with downregulation of transcription factors Sp1/3/4

Glenmark Pharma begins IND-enabling studies for GBR-401

Orexo advances development of OX-51 for pain

CPP-109 enters trial for cocaine and alcohol addiction

Astellas licenses three agents to Cardeus Pharma

America Stem Cell's ASC-101 obtains FDA orphan drug status

Novel microtubule-disrupting agents claimed

Enrollment begins in phase III EMPOWER trial of dexpramipexole in ALS

NeuroSearch patents new modulators of voltage-gated potassium channels

ISP Investments presents new protein-glutamine gamma-glutamyltransferase activator

Quest Diagnostics acquires Athena Diagnostics

Pfizer receives FDA refuse to file letter for tafamidis in TTR-FAP

Avanir Pharma files IND for AVP-923 for neuropathic pain in MS

Tibotec scientists design novel anti-HCV agents

New inhibitors of cyclin-dependent kinase 9 patented by Novartis

Pan-Akt inhibitor GDC-0068 demonstrates in vivo antitumor effects

Morphotek acquires tumor-targeting peptide platform from TransMolecular

Boston Scientific reports data on new alloy and stent design

Final SELECT-2 data show CR2b is efficacious against hepatitis C when dosed every 2 weeks

Daiichi Sanyko completes acquisition of Plexxikon

Reporting of final results of phase II AZX-100 trial to be delayed

Abstral launched in U.S. for breakthrough cancer pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....